VIDAS® Fertility Assays
For the Investigation and Treatment of Infertility
The VIDAS Fertility Assays provides key diagnostic tools for the investigation of reproductive hormone dysfunctions such as precocious and delayed puberty, amenorrhea, hirsutism, hyperprolactinemia, perimenopause and menopause, hypogonadism, gynecomastia, and azoospermia.
Disclaimer: Product availability varies by country. Please consult your local bioMérieux representative for product availability in your country.
- VIDAS-3
- VIDAS-hormone-fertility-assays
What is Hormone Testing?
Hormones are responsible for regulating and controlling a wide range of physiological processes in the body, including metabolism, growth and development, reproduction, mood, and stress response. While hormonal imbalances can lead to symptoms that affect quality of life, they can also lead to the development of significant challenges with fertility and reproductive health, adrenal gland disorders, and thyroid disorders.
Since the cornerstone of any effective treatment depends on accurate diagnosis, quality diagnostic testing must be used to accurately test hormone levels. Immunoassay testing is commonly used to test hormones due to its ability to detect and quantify specific substances in samples accurately and efficiently. This type of testing allows healthcare providers to make informed decisions about patient care, develop appropriate treatment plans, and improve overall health and well-being.
Without effective strategies for hormone testing, the healthcare burden can potentially be significant. Delayed diagnosis and misdiagnosis, ineffective treatment, health complications, increased healthcare costs, adverse effects of hormone therapies, and challenges in fertility and reproductive health all contribute to the overall healthcare burden.
The VIDAS Fertility Assays
The VIDAS Fertility Assays include four fully automated hormone tests for the quantitative measurement of luteinizing hormone (LH), follicle-stimulating hormone (FSH), estradiol II, and progesterone. The assays are designed to be a convenient solution for fertility centers to perform on-site testing.
Precise and Sensitive Tools
Clinical evaluation of the VIDAS® Estradiol II and VIDAS® Progesterone assays has confirmed their reliability for use in evaluating natural cycles and monitoring ovarian superovulation:1 They have proven accuracy in the low concentration range when confirming pituitary suppression after GnRH-agonist therapy. There is also a strong correlation between serum estradiol measured by VIDAS Estradiol II and follicular measures made by ultrasonography during gonadotropin treatment with both GnRH analogue protocols.
Testing Made Simple for Laboratories
Assays
Technical Specifications
| Assay | Part Number | Code | Number of Tests Per Kit | Time to Result | Measurement Range |
|---|---|---|---|---|---|
| VIDAS® Estradiol II | 30431-01 | E2II | 60 tests | 60 | 9 - 3,000 pg/mL |
| VIDAS® Progesterone | 30409-01 | PRG | 60 tests | 45 | 0.25 - 80 ng/mL |
| VIDAS® FSH | 30407-01 | FSH | 60 tests | 40 | 0.1 - 110 mIU/mL |
| VIDAS® LH | 30406-01 | LH | 60 tests | 40 | 0.1 - 100 mIU/mL |
Reference
1. E. Anckaert et al. Clinical Validation of a Fully Automated 17β-Estradiol and Progesterone Assay (VIDAS®) for Use in Monitoring Assisted Reproduction Treatment. Clin Chem Lab Med 2002; 40(8):824-831.
2. bioMérieux. VIDAS 3 User Manual US Version. No. rev. 161150-465D.
